Published • loading... • Updated
Supriya Lifescience Delivers Strong FY26 Performance; Q4 Revenue Surges 50% YoY
Summary by THE TIMES OF BENGAL
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Supriya Lifescience Delivers Strong FY26 Performance; Q4 Revenue Surges 50% YoY
The unaudited financial statements for Q4FY26 have been released by Supriya Lifescience Ltd., a cGMP-compliant business with a strong track record in API manufacturing and a focus on products from a variety of therapeutic segments, including anti-histamine, anti-allergic, vitamin, anaesthetic, and anti-asthmatic. The company has spread its business in more than 120 countries across the globe. Key Consolidated Financial Highlights: ParticularsQ4 …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
